Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

For patients with acute myeloid and lymphoblastic leukaemia (AML/ALL) lacking a matched sibling or unrelated donor, haploidentical stem cell transplantation (HAPLO-SCT) is increasingly used. However, available data on the treatment of relapse after HAPLO-SCT, including feasibility and efficacy of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippini Velázquez, Giuliano, Labopin, Myriam, Tischer, Johanna, Raiola, Anna Maria, Angelucci, Emanuele, Kulagin, Alexander D., Galieni, Piero, Bermúdez, Arancha, Bulabois, Claude-Eric, Kröger, Nicolaus, Díez-Martín, José Luis, Kwon, Mi, Nagler, Arnon, Schmid, Christoph, Ciceri, Fabio, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400422/
https://www.ncbi.nlm.nih.gov/pubmed/37160941
http://dx.doi.org/10.1038/s41409-023-01985-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400422/
https://www.ncbi.nlm.nih.gov/pubmed/37160941
http://dx.doi.org/10.1038/s41409-023-01985-7

Ejemplares similares